Don’t miss Synthetic Biology US 2024! Join leading omics experts and researchers for a two-day event accelerating the development of synthetic biology tools to enable effective therapeutics development. Returning for [….]
Synthetic Biology US 2024
5 Questions with Brandan Jason, Automation Sales Executive, Mid-Atlantic, Opentrons
Brandan Jason is a current resident of Gaithersburg, MD, and has lived in Montgomery County for the past five years. He grew up in upstate New York and attended St. John Fisher College. Brandan loves to network and make new connections. He is passionate about helping others and giving back to the community by volunteering with groups like The Miracle League and Roc Solid Foundation. Outside of work, he also enjoys spending time with family, playing golf, and visiting craft breweries.
QIAGEN forms strategic alliance with Sysmex Corporation for global cancer companion diagnostics development and commercialization using NGS and Plasma-Safe-SeqS technology
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a global strategic alliance with Japan’s Sysmex Corporation (Tokyo Stock Exchange, First Section [Ticker Code: 6869]) for the development and commercialization of cancer companion diagnostics, which will leverage both QIAGEN’s leadership in this field and Sysmex’s Plasma-Safe-SeqS technology for next generation sequencing (NGS).